Related Experiment Videos
[Blood bunaphthine during dynamic physical exercise and anti-arrhythmic action]
Giornale Italiano Di Cardiologia
|January 1, 1976
Summary
Bunaphtine effectively prevented ventricular arrhythmias and significantly reduced supraventricular arrhythmias by 80% in patients during exercise stress tests. This study highlights bunaphtine
Area of Science:
- Pharmacology
- Exercise Physiology
- Cardiology
Context:
- Submaximal exercise can trigger or exacerbate cardiac arrhythmias.
- Ventricular and supraventricular extrasystoles are common findings during ergometric testing.
- Bunaphtine is an antiarrhythmic agent under investigation.
Purpose:
- To evaluate the pharmacokinetic profile and antiarrhythmic efficacy of bunaphtine during submaximal exercise.
- To determine the effectiveness of bunaphtine in preventing and managing exercise-induced arrhythmias.
- To establish an optimal dosing regimen for bunaphtine in this context.
Summary:
- Bunaphtine was administered intravenously to 5 patients experiencing arrhythmias during bicycle ergometry.
- A loading dose followed by a continuous infusion maintained steady-state bunaphtinemia above the minimum effective concentration.
- The drug successfully prevented ventricular arrhythmias and reduced supraventricular arrhythmias by 80%.
Impact:
- Bunaphtine demonstrates significant potential as a therapeutic agent for exercise-induced cardiac arrhythmias.
- The findings support the use of bunaphtine for managing patients with exercise-related ventricular and supraventricular arrhythmias.
- This study provides a basis for further clinical trials investigating bunaphtine's antiarrhythmic properties.